We can take you further
and enhance your strenghts
The ongoing transformation of the Pharmaceutical and Medical Device Industries has a direct impact on their suppliers of original equipment and manufacturing solutions. Pharma and Medical OEM’s are experiencing a significant change in their customer base, once dominated almost exclusively by big pharmaceutical companies, and now including Generic Manufacturers and CMO’s who jointly comprises no less than 50% of sales.
To win in this new environment, Pharma and Medical OEM’s have to transform themselves, rethinking their business strategy, offering the right product to the right customer segments, producing equipment and parts quicker and more cost effectively and improving the organization’s overall service, flexibility and responsiveness. Achieving this degree of transformation is not easy, but keeping the status quo is not an option.
Areas of Our Consulting Expertise
We bring fresh insight to the application of proven tools, such as VA/VE, helping medical equipment and pharmaceutical companies transform R&D effectiveness, acquisition integration, supply chain transformation, asset productivity and margin improvement.
Our global team of consultants, and our industry partners such as Biocom, have a depth of technical operations expertise and a proven track record of leading and implementing successful transformations through Pharmaceuticals Equipment Manufacturing Consulting. Our people bring a wide range of professional experience from some of the most operationally excellent companies in the world in several areas of Medical Technologies.
Our global team of consultants has a depth of technical operations expertise and a proven track record of leading and implementing successful transformations. Our people bring a wide range of professional experience from some of the most operationally excellent companies in the world.
We bring our worldwide experienced and success across many healthcare sectors to each client engagement. Our focus is always to achieve and sustain superior levels of performance through:
We have deep experience on both the buy and sell-side, and work with our clients to ensure that partnership, licensing and investment decisions are taken with confidence, along with clear alignment between transaction price and asset value.
About our business development capabilities
Our technical and scientific expertise allows it to deeply understand the science behind biotech and pharmaceutical assets – a core advantage in all business development work that we do. Whether it’s in the ability to recognize potential assets when scouting, in developing the right assumptions for a valuation model, or with delivering due diligence that provides a complete and accurate assessment, knowing the science makes us more effective.
Our consultants average 20-30 years of industry experience and bring significant first-hand knowledge to every project. Our core team works hand in hand with our Expert Network, which contains over 100 expert business development consultants, and more than 500 high-caliber consultants in total. Having this substantial resource at our fingertips allows us to provide precisely relevant expertise tailored to the specifics of each project, across a full range of product modalities and disease areas.